InflaRx N.V. Reports 2024 Annual Meeting Results

Ticker: IFRX · Form: 6-K · Filed: Apr 24, 2025 · CIK: 1708688

Sentiment: neutral

Topics: annual-meeting, financial-results, corporate-governance

TL;DR

InflaRx shareholders approved the 2024 annual accounts on April 24, 2025.

AI Summary

InflaRx N.V. held its Annual General Meeting of Shareholders on April 24, 2025. The primary agenda item was the adoption of the Dutch statutory annual accounts for the financial year ended December 31, 2024. The results of this vote, along with other agenda items, were finalized and reported.

Why It Matters

This filing confirms the official adoption of InflaRx's 2024 financial accounts by its shareholders, providing transparency on the company's fiscal performance.

Risk Assessment

Risk Level: low — The filing is a routine report of an annual general meeting's outcomes and does not introduce new financial or operational risks.

Key Players & Entities

FAQ

What was the main purpose of the Annual General Meeting held on April 24, 2025?

The main purpose was the adoption of the Dutch statutory annual accounts for the financial year ended December 31, 2024.

Which form is InflaRx N.V. required to file annually?

InflaRx N.V. is required to file annual reports under cover of Form 20-F.

What is the principal executive office address of InflaRx N.V.?

The principal executive office is located at Winzerlaer Str. 2, 07745 Jena, Germany.

When did the company change its name from Fireman B.V.?

The company changed its name from Fireman B.V. on June 6, 2017.

What is the SIC code for InflaRx N.V.?

The Standard Industrial Classification code for InflaRx N.V. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on April 24, 2025 regarding InflaRx N.V. (IFRX).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing